Clinical trial Recruiting at 1 site Interventional

Evaluating a semantic recognition task in Alzheimer Disease

Official title: A Sensitive Measurement Proposal in Alzheimer's Disease: Semantic Recognition Task

Run by Istanbul University · NCT05711888 · Data updated 2026-11-12

This study tests a special memory task for people with Alzheimer’s to see how it relates to brain activity and could help improve diagnosis and treatment.

Quick facts

Study typeInterventional
SexAll
Enrollment80 (estimated)
SponsorIstanbul University
Academic / other
Locations1 site (Beşiktaş, Istanbul)
StatusRecruiting
StartedDecember 21, 2022
Main results expectedSeptember 20, 2025
Study endsDecember 26, 2027
Registry record updatedOctober 2, 2024
Trial IDNCT05711888 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are individuals diagnosed with Alzheimer Disease who have undergone biomarker analysis.

Probably not a fit

Patients who are illiterate may not benefit from this study due to the nature of the semantic recognition tasks involved.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to observe the outcomes of a semantic recognition task specifically designed for patients with Alzheimer Disease. It focuses on understanding how this task relates to temporal lobe activity, which is crucial for memory function. By utilizing a recognition procedure that goes beyond traditional memory testing, the study seeks to provide insights that could enhance clinical practice in diagnosing and managing Alzheimer Disease. Participants will undergo biomarker analysis to confirm their Alzheimer's status.

Why it matters

Potential benefit: If successful, this study could lead to improved diagnostic tools and interventions for patients with Alzheimer Disease.

How similar studies have gone: While this approach is innovative, similar studies have not been extensively documented, indicating a novel exploration in the field.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* to have biomarker analysis for Alzheimer disease (positive or negative).

Exclusion Criteria:

* illiteracy

Where it's running

  • Jbid Dursun Uncu
    Beşiktaş, Istanbul, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.